Related by context. Frequent words. (Click for all words.) 65 Repros Therapeutics Inc. 63 RPRX 60 Barrier Therapeutics Inc. 60 ADVENTRX Pharmaceuticals Inc. 60 Nasdaq Hearings Panel 59 Repros Therapeutics 59 IMPAX Laboratories Inc. 58 AVANIR Pharmaceuticals 58 NASDAQ Listing 57 EPIX Pharmaceuticals Inc. 57 NasdaqCM 57 Cyclacel Pharmaceuticals Inc. 57 Company Nasdaq PRGO 57 Complete Response letter 56 FDA approvable letter 56 Full Prescribing Information 55 Neose Technologies Inc. 55 AMAG Pharmaceuticals Inc. 55 MiddleBrook Pharmaceuticals Inc. 55 Staff Determination Letter 55 Unilife Corporation 55 FDA Accepts 55 Complete Response 55 Medicis Pharmaceutical Corporation 54 Commence Trading 54 Lexicon Pharmaceuticals 54 Oscient Pharmaceuticals Corporation 54 Completes Enrollment 54 Shelf Registration Statement 54 BioDelivery Sciences 54 Citizen Petition 53 Golar LNG Limited 53 Intellect Neurosciences Inc. 53 Altus Pharmaceuticals Inc. 53 HEICO Corporation 53 Commences Trading 53 www.exelixis.com 53 Q2 Loss Narrows 53 submitted Marketing Authorization 53 symbol GGP 53 Positive Opinion 53 Listing Qualifications Panel 53 Sunesis Pharmaceuticals 53 Zonagen 53 Clinical Trial Results 53 Euronext Brussels DELB 52 FDA Clearance 52 Webcast Annual Meeting 52 Immunicon Corporation 52 Continued Listing 52 Act PDUFA date 52 NASDAQ STEM 52 Cardium Therapeutics Inc. 52 Javelin Pharmaceuticals 52 Complete Response Letter 52 Hold Fourth Quarter 52 XTL Biopharmaceuticals Ltd. 52 Advanced Magnetics 51 Marketing Authorization 51 FDA Clears 51 Pulmonary Arterial Hypertension 51 Merge Healthcare Incorporated 51 Patient Enrollment 51 AVANT Immunotherapeutics Inc. 51 Drug Candidate 51 Approvable Letter 51 Staff Deficiency Letter 51 pinksheets 50 Option Grants 50 BioSante Pharmaceuticals 50 FUQI International 50 Symbol Change 50 Share Repurchases 50 symbol DIB 50 Receives Notice 50 Prescribing Information 50 JWb 50 www.gsk.com 50 Extended Release 50 3rd Quarter Results 50 Q2 Loss Widens 50 Cytogen Corporation 50 Generic Version 50 Notice Regarding 50 China Shenghuo 49 Drug Application 49 Nasdaq Listing Rule 49 Marketing Authorization Application 49 Endwave Corporation 49 Updates Guidance 49 NASDAQ SmallCap 49 EpiCept Corporation 49 Shareholder Update 49 Final Approval 49 MRV Communications Inc. 49 FDA Orphan Drug 49 DUSA Pharmaceuticals Inc. 49 NYSE Amex Equities 49 Minimum Bid Price 48 NASDAQ Listing Qualifications 48 symbols JWa